These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 8137237

  • 1. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
    Sala A, Nicolaides NC, Engelhard A, Bellon T, Lawe DC, Arnold A, Graña X, Giordano A, Calabretta B.
    Cancer Res; 1994 Mar 15; 54(6):1402-6. PubMed ID: 8137237
    [Abstract] [Full Text] [Related]

  • 2. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F, Lovec H, Möröy T, Lipp M.
    Oncogene; 1994 Jul 15; 9(7):2029-36. PubMed ID: 8208548
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H, Iavarone A, Reeves SA.
    Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018
    [Abstract] [Full Text] [Related]

  • 4. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG.
    Oncogene; 1995 Nov 02; 11(9):1685-92. PubMed ID: 7478595
    [Abstract] [Full Text] [Related]

  • 5. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 02; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 6. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 7. Functional roles of E2F in cell cycle regulation.
    Fan J, Bertino JR.
    Oncogene; 1997 Mar 13; 14(10):1191-200. PubMed ID: 9121768
    [Abstract] [Full Text] [Related]

  • 8. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K.
    Oncogene; 1999 Nov 04; 18(46):6398-402. PubMed ID: 10597240
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D, Schulze A, Boye B, Jansen-Dürr P.
    Cell Growth Differ; 1997 Jun 04; 8(6):699-710. PubMed ID: 9186003
    [Abstract] [Full Text] [Related]

  • 10. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
    Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Smulson ME.
    Oncogene; 1999 Sep 09; 18(36):5015-23. PubMed ID: 10490838
    [Abstract] [Full Text] [Related]

  • 11. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B, Farmer AA, Lee WH.
    Cell Growth Differ; 1996 Jun 09; 7(6):689-97. PubMed ID: 8780882
    [Abstract] [Full Text] [Related]

  • 12. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC, Pützer B, Schwabe G, Gnauck HK, Schulte Holthausen H.
    Cell Mol Biol Res; 1993 Jun 09; 39(8):705-16. PubMed ID: 7951410
    [Abstract] [Full Text] [Related]

  • 13. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 14. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
    Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, Nojima H.
    Oncogene; 1999 Apr 08; 18(14):2299-309. PubMed ID: 10327050
    [Abstract] [Full Text] [Related]

  • 15. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J, Illenye S, Chang YC, Mitsui Y, Heintz NH.
    Oncogene; 1999 Jan 21; 18(3):593-605. PubMed ID: 9989809
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
    Jiang H, Lin J, Young SM, Goldstein NI, Waxman S, Davila V, Chellappan SP, Fisher PB.
    Oncogene; 1995 Sep 21; 11(6):1179-89. PubMed ID: 7566979
    [Abstract] [Full Text] [Related]

  • 17. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC.
    Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075
    [Abstract] [Full Text] [Related]

  • 18. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H, Geymayer S, Haidweger E.
    J Mol Biol; 1999 Nov 12; 293(5):1005-15. PubMed ID: 10547281
    [Abstract] [Full Text] [Related]

  • 19. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A, Zerfass K, Spitkovsky D, Henglein B, Jansen-Dürr P.
    Oncogene; 1994 Dec 12; 9(12):3475-82. PubMed ID: 7970707
    [Abstract] [Full Text] [Related]

  • 20. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.
    Clin Cancer Res; 2000 Apr 12; 6(4):1488-97. PubMed ID: 10778981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.